Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.52, ss.68-73, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., Onel D., et al.
POSTGRADUATE MEDICINE , cilt.128, sa.4, ss.432-438, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

Ormeci A., Akyuz F., BARAN B., SOYER O., GÖKTÜRK S., ONEL M., et al.
European Review for Medical and Pharmacological Sciences , cilt.20, sa.5, ss.858-865, 2016 (SCI-Expanded) identifier identifier identifier

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
LIVER INTERNATIONAL , cilt.35, sa.10, ss.2265-2274, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Acute hepatitis B due to immune-escape mutations in a naturally immune patient

Kaymakoglu S., Baran B., Onel D., Badur S., Atamer T., Akyuz F.
ACTA GASTRO-ENTEROLOGICA BELGICA , sa.2, ss.262-265, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B

KESKİN O., Ormeci A., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.
ANTIVIRAL THERAPY , cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients

Mese S., Arikan M., Cakiris A., Abaci N., Gumus E., Kursun O., et al.
JOURNAL OF GENERAL VIROLOGY , cilt.94, ss.2729-2738, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naive Patients with Chronic Hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Bozbey H. U., et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.57, sa.4, ss.1790-1796, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.

Pinarbasi B., Onel D., Cosan F., Akyuz F., Dirlik N., Cakaloglu Y., et al.
Liver international : official journal of the International Association for the Study of the Liver , cilt.29, sa.2, ss.227-30, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Acute hepatitis A virus infection in Turkey

Normann A., Badur S., Oenel D., Kılıç A., Sidal M., Larouze B., et al.
JOURNAL OF MEDICAL VIROLOGY , cilt.80, sa.5, ss.785-790, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Mutations in influenza A virus (H5N1) and possible limited spread, Turkey, 2006

Altiok E., Taylan F., Yenen O. Ş., Demirkeser G., Bozaci M., Oenel D., et al.
EMERGING INFECTIOUS DISEASES , cilt.14, sa.3, ss.491-492, 2008 (SCI-Expanded) identifier identifier identifier

Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

Kaymakoglu S., Danalioglu A., Demir K., Karaca C., Akyuz F., Onel D., et al.
Digestive Diseases and Sciences , cilt.52, sa.3, ss.727-731, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection

Besisik F., Karaca Q., Akyuz F., Horosanli S., Onel D., Badur S., et al.
JOURNAL OF HEPATOLOGY , cilt.38, sa.4, ss.506-510, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine

Kazancioglu R., Sever M., Yuksel-Onel D., Eraksoy H., Yildiz A., Celik A., et al.
CLINICAL TRANSPLANTATION , cilt.14, sa.1, ss.61-65, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Immune response to Haemophilus influenzae type b vaccination in renal transplant recipients with well-functioning allografts

Sever M., Yildiz A., Eraksoy H., Badur S., Yuksel-Onel D., Gorcin B., et al.
NEPHRON , cilt.81, sa.1, ss.55-59, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013 identifier

Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

Ormeci A., Akyuz F., Baran B., Soyer O. M., Gokturk S., Karaca C., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013 Sürdürülebilir Kalkınma identifier

Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013 Sürdürülebilir Kalkınma identifier

Investigation of resistance mutations in the HBV DNA samples that isolated from patients with chronic Hepatitis nucleoside/nucleotide analogues by INNO-LIPA HBV DR and ultradeep pyrosequencing methods

MEŞE S., ARIKAN M., ÇAKİRİS A., ABACI N., ÖNEL D., USTEK D., et al.
2nd World Congress on Virology, Las Vegas, Amerika Birleşik Devletleri, 20 - 22 Ağustos 2012, cilt.4, sa.4, ss.147 Sürdürülebilir Kalkınma

Metrikler

Yayın

20

Atıf (WoS)

301

H-İndeks (WoS)

10

Atıf (Scopus)

328

H-İndeks (Scopus)

11
BM Sürdürülebilir Kalkınma Amaçları